Four Type 2 diabetes drugs are in CMS’ lineup of the 10 drugs that face price negotiations between the agency and their makers.
Read the full post on Becker's Hospital Review - Healthcare News
CMS names 10 drugs for price negotiations
Four Type 2 diabetes drugs are in CMS’ lineup of the 10 drugs that face price negotiations between the agency and their makers.
Read the full post on Becker's Hospital Review - Healthcare News